Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study of XW003 Injection in Chinese Adolescents With Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating XW003 Injection for obesity in Chinese adolescents is ongoing but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XW003 Injection (XW003)

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: Obese Adolescents, Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING